US$ 29.81
glp-1 iih Receptor Agonists in Idiopathic Intracranial Hypertension: A Systematic Review | Headache Journal (Headache: The Journal of Head & Face Pain) posted on the topic Metabolic Concepts in Idiopathic Intracranial
Description
Pinto M et al

You finally took the plunge and started taking a GLP-1 drug to improve your health

For example, metformin lowers weight by an average of six to nine pounds in three months, and those benefits are greater when it is started early

The FDA is requiring warning label changes to all glucagon-like peptide 1 (GLP-1) receptor agonist medications a newer class of drugs used for the treatment of diabetes and obesity regarding the risk of serious kidney injury that can result from dehydration, requiring the need for hemodialysis treatment

Gagnon Eloi, Mitchell PatriciaL, Arsenault BenoitJ
